Browse our extensive catalog of high-quality chemicals for research and development.
| Product Name | Description | CAS Number | Molecular Formula | Molecular Weight | Description |
|---|---|---|---|---|---|
| (alphaR,betaR)-beta-(2,4-Difluorophenyl)-beta-hydroxy-alpha-methyl-1H-1,2,4-triazole-1-butanoic Acid | [R-(R*,R*)]-β-(2,4-Difluorophenyl)-β-hydroxy-α-methyl-1H-1,2,4-triazole-1-butanoic Acid; | 166948-49-8 | C13H13F2N3O3 | 297.26 | [R-(R*,R*)]-β-(2,4-Difluorophenyl)-β-hydroxy-α-methyl-1H-1,2,4-triazole-1-butanoic Acid;
|
| (alphaR,betaR)-beta-(2,4-Difluorophenyl)-beta-hydroxy-alpha-methyl-1H-1,2,4-triazole-1-butanoic Acid-d3 | [R-(R,R)]-beta-(2,4-Difluorophenyl)-beta-hydroxy-alpha-methyl-1H-1,2,4-triazole-1-butanoic Acid-d3; | 1329610-75-4 | C13H10D3F2N3O3 | 300.28 | [R-(R,R)]-beta-(2,4-Difluorophenyl)-beta-hydroxy-alpha-methyl-1H-1,2,4-triazole-1-butanoic Acid-d3;
|
| 21-Desacetyl-21-isovaleroyl Difluprednate | 2-((6S,8S,9R,10S,11S,13S,14S,17R)-17-(Butyryloxy)-6,9-difluoro-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl 3-Methylbutanoate | C30H40F2O7 | 550.63 | 2-((6S,8S,9R,10S,11S,13S,14S,17R)-17-(Butyryloxy)-6,9-difluoro-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopen... | |
| 21-Desacetyl-21-isovaleroyl-d3 Difluprednate | 2-((6S,8S,9R,10S,11S,13S,14S,17R)-17-(Butyryloxy)-6,9-difluoro-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl-d3 3-Methylbutanoate | C30H37D3F2O7 | 553.65 | 2-((6S,8S,9R,10S,11S,13S,14S,17R)-17-(Butyryloxy)-6,9-difluoro-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopen... | |
| 5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole | 5-(Difluoromethoxy)-1,3-dihydro-2H-benzimidazole-2-thione; 5-Difluoromethoxy-2-mercaptobenzimidazole; SKA 47; USP Pantoprazole Related Compound C; Pantoprazole EP Impurity C; Pantoprazole USP Related Compound C | 97963-62-7 | C8H6F2N2OS | 216.21 | 5-(Difluoromethoxy)-1,3-dihydro-2H-benzimidazole-2-thione; 5-Difluoromethoxy-2-mercaptobenzimidazole; SKA 47; USP Pantoprazole Related Compound C; Pan... |
| DL-alpha-(Difluoromethyl)arginine | 2-(Difluoromethyl)arginine; alpha-(Difluoromethyl)-DL-arginine; alpha-Difluoromethylarginine; DFMA; RMI 71897; | 69955-43-7 | C7H14F2N4O2 | 224.21 | 2-(Difluoromethyl)arginine; alpha-(Difluoromethyl)-DL-arginine; alpha-Difluoromethylarginine; DFMA; RMI 71897;
|
| DL-alpha-Difluoromethylornithine Hydrochloride | DFMO HCl; Eflornithine Hydrochloride; NSC 270295; NSC 337250; Vaniqa; 2-(Difluoromethyl)-ornithine Monohydrochloride; 2-(Difluoromethyl)-DL-ornithine Monohydrochloride; | 68278-23-9 | C6H12F2N2O2• (HCl) | 182.173646 | DFMO HCl; Eflornithine Hydrochloride; NSC 270295; NSC 337250; Vaniqa; 2-(Difluoromethyl)-ornithine Monohydrochloride; 2-(Difluoromethyl)-DL-ornithine ... |
| Difluoromethylenediphosphonic Acid | P,P-(Difluoromethylene)bisphosphonic Acid; Difluoromethylene)bis[phosphonic Acid]; (Difluoromethylene)bisphosphonic Acid; | 10596-32-4 | CH4F2O6P2 | 211.98 | P,P-(Difluoromethylene)bisphosphonic Acid; Difluoromethylene)bis[phosphonic Acid]; (Difluoromethylene)bisphosphonic Acid;
|
| Difluoromethylenediphosphonic Acid Sodium Salt | P,P-(Difluoromethylene)bisphosphonic Acid Sodium Salt (1:4); Tetrasodium Difluoromethylenediphosphonate | 948024-84-8 | CF2Na4O6P2 | 299.91 | P,P-(Difluoromethylene)bisphosphonic Acid Sodium Salt (1:4); Tetrasodium Difluoromethylenediphosphonate
|
| 5-(Difluoromethyl)-2-pyrazinamine | 1785551-80-5 | C5H5F2N3 | 145.11 |
Page 6743 of 10017